Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
| Weiss Ratings | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | D+ | |||
| Rating Factors | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.69 | |||
| 52-Week Low Price | $0.69 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Apr 07, 2025 | |||
| Valuation | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.33B | |||
| Enterprise Value | 2.23B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | -133.84% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.01 | |||
| Price/Book (Q) | 1.85 | |||
| Enterprise Value/Revenue (TTM) | 1.77 | |||
| Price | $0.69 | |||
| Enterprise Value/EBITDA (TTM) | 9.78 | |||
| Enterprise Value/EBIT | 12.02 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 2.55B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -38.04% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 86 25 8556 6666 | |||
| Address | -- | |||
| Website | www.simcere.com | |||
| Country | China | |||
| Year Founded | 1995 | |||
| Profitability | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.74% | |||
| Profit Margin | -17.35% | |||
| Management Effectiveness | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.81% | |||
| Return on Equity | -- | |||
| Income Statement | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 878.26M | |||
| Total Revenue (TTM) | 878.26M | |||
| Revenue Per Share | $0.34 | |||
| Gross Profit (TTM) | 676.49M | |||
| EBITDA (TTM) | 159.06M | |||
| EBIT (TTM) | 129.49M | |||
| Net Income (TTM) | -152.38M | |||
| Net Income Avl. to Common (TTM) | -152.38M | |||
| Total Revenue Growth (Q YOY) | -10.91% | |||
| Earnings Growth (Q YOY) | -80.56% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | -79.80% | |||
| Balance Sheet | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 420.59M | |||
| Cash Per Share (Q) | $0.16 | |||
| Total Current Assets (Q) | 883.19M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 950.71M | |||
| Current Ratio (Q) | 2.099 | |||
| Book Value Per Share (Q) | $0.37 | |||
| Total Assets (Q) | 1.61B | |||
| Total Current Liabilities (Q) | 420.68M | |||
| Total Debt (Q) | 162.64M | |||
| Total Liabilities (Q) | 661.14M | |||
| Total Common Equity (Q) | 950.71M | |||
| Cash Flow | SMHGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -92.30M | |||
| Cash from Financing (TTM) | -17.02M | |||
| Net Change in Cash (TTM) | 42.89M | |||
| Levered Free Cash Flow (TTM) | 11.18M | |||
| Cash from Operations (TTM) | 151.87M | |||
